Skip to main content
    B

    Bio-Rad Laboratories Inc (BIO-B)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $364.15
    -0.93 (-0.25%)

    Market Cap: $9.76B

    Last updated: Oct 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    70%(21/30)
    Avg Surprise
    +24.74%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $650M
    Range$648M - $652M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-N/A---
    Jun 26
    Reported Aug 4
    		$13.85N/AN/ABeat+18.7%
    Mar 26
    Reported Apr 30
    		$-19.55N/AN/ABeat-954.0%
    Dec 25
    Reported Feb 12
    		$26.65$0.00N/ABeat+204.3%
    Sep 25
    Reported Oct 28
    		$-12.70$0.00N/ABeat-154.4%
    Jun 25
    Reported Jul 30
    		$11.67$0.00N/ABeat+115.3%
    Mar 25
    Reported May 5
    		$2.29$0.00N/ABeat-83.0%
    Dec 24
    Reported Feb 13
    		$-25.57$0.00N/ABeat-924.7%
    Sep 24
    Reported Oct 30
    		$23.34N/AN/ABeat+901.7%
    Jun 24
    Reported Aug 1
    		$-76.26N/AN/ABeat-2642.1%
    Mar 24
    Reported May 7
    		$13.45$2.99+349.94%Beat+302.8%
    Dec 23
    Reported Feb 29
    		$3.10$2.84+9.15%Beat-6.3%
    Sep 23
    Reported Oct 27
    		$2.33$2.76-15.58%Miss-10.4%
    Jun 23
    Reported Aug 4
    		$3.00$2.64+13.64%Beat-11.2%
    Mar 23
    Reported May 5
    		$3.34$3.63-7.99%Miss-32.4%
    Dec 22
    Reported Feb 17
    		$3.31$3.48-4.89%Miss+3.1%
    Sep 22
    Reported Oct 28
    		$2.60$2.70-3.70%Miss-29.9%
    Jun 22
    Reported Jul 29
    		$3.38$2.72+24.26%Beat-4.5%
    Mar 22
    Reported Apr 29
    		$4.94$3.34+47.90%Beat-5.2%
    Dec 21
    Reported Feb 11
    		$3.21$2.82+13.83%Beat-20.0%
    Sep 21
    Reported Oct 29
    		$3.71$2.31+60.61%Beat+23.7%
    Jun 21
    Reported Jul 30
    		$3.54$2.55+38.82%Beat+119.9%
    Mar 21
    Reported Apr 30
    		$5.21$2.96+76.01%Beat+172.8%
    Dec 20
    Reported Feb 12
    		$4.01$3.24+23.77%Beat+72.8%
    Sep 20
    Reported Oct 30
    		$3.00$1.80+66.67%Beat+86.3%
    Jun 20
    Reported Jul 30
    		$1.61$1.22+31.97%Beat+2.5%
    Mar 20
    Reported May 6
    		$1.91$1.57+21.66%Beat+15.8%
    Dec 19
    Reported Feb 13
    		$2.32$2.44-4.92%Miss+8.9%
    Sep 19
    Reported Oct 31
    		$1.61$1.41+14.18%Beat+76.9%
    Jun 19
    Reported Aug 1
    		$1.57$1.32+18.94%Beat-4.3%
    Mar 19
    Reported May 8
    		$1.65$1.14+44.74%Beat+41.0%
    Dec 18
    Reported Feb 28
    		$2.13$1.70+25.29%Beat+317.6%
    Sep 18
    Reported Nov 1
    		$0.91$1.18-22.88%Miss+0.0%
    Jun 18
    Reported Aug 7
    		$1.64$1.27+29.13%Beat+864.7%
    Mar 18
    Reported Apr 13
    		$1.17$1.07+9.35%Beat+178.6%
    Dec 17
    Reported Feb 27
    		$0.51N/A-59.52%Miss+172.9%
    Sep 17
    Reported Nov 2
    		$0.91$0.38+139.47%Beat-
    Jun 17
    Reported Aug 3
    		$0.17N/A-69.64%Miss-
    Mar 17
    Reported May 4
    		$0.42$0.30+40.00%Beat-
    Dec 16
    Reported Feb 23
    		$-0.70$1.03-167.96%Miss-

    Key Metrics

    Valuation
    P/E Ratio44.12EV/EBITDA20.31x
    Price/FCF27.65xFCF Yield3.62%
    Profitability
    Profit Margin8.59%Operating Margin11.20%
    ROE3.11%ROIC3.10%
    Financial Health
    Debt/Equity0.17xInterest Coverage8.18x
    Current Ratio3.14xQuick Ratio2.33x
    Trading Statistics
    Beta1.07Avg Volume26
    52-Week High$401.5952-Week Low$244.54

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$364.99
    SMA 20$365.03
    SMA 50$358.88
    SMA 200$307.53
    EMA 10$364.90
    EMA 20$364.26
    EMA 50$354.52
    EMA 200$316.36

    MACD

    Line: 1.86Signal: 2.74Hist: -0.88

    ADX

    ADX: 88.6+DI: 71.1-DI: 28.8

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down100.0
    PSAR$363.00

    Bollinger Bands

    Upper Band$365.45
    Lower Band$364.62
    %B Position23%(Middle)
    Band Width-0.56

    RSI (14-Day)

    Overbought
    71.3

    Momentum Oscillators

    Stoch %KN/A
    Stoch %DN/A
    Williams %R-100.0
    ROC (10d)-0.3%
    Momentum-0.93
    CCI (20d)-666.7
    MFI (14d)N/A

    Volatility Measures

    ATR (14d)$0.25(0.1%)
    StdDev (20d)0.21
    Hist Vol0.9%(Low)

    Volume Flow

    VWAP$364.17
    OBV2.6K
    AD Line6.9K
    CMF (20d)-0.411

    Volume Metrics

    Avg Vol (20d)0.0K
    Vol Ratio8.2x(High)
    VWMA (20d)$364.70

    Pivot Points

    R3$365.08
    R2$365.08
    R1$365.08
    Pivot Point$365.08
    S1$365.08
    S2$365.08
    S3$365.08

    Advanced Oscillators

    TSI88.64
    Ultimate OscN/A
    KST13.11

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$651.00M$592.10M$693.20M$653.00M$651.60M$585.40M$667.48M$649.73M$638.48M$610.82M$681.18M$632.12M
    Cost of Revenue$305.20M$282.70M$348.00M$309.60M$306.30M$279.40M$325.56M$293.83M$282.76M$284.35M$315.28M$296.44M
    Gross Profit$345.80M$309.40M$345.20M$343.40M$345.30M$306.00M$341.91M$355.90M$355.12M$326.47M$365.90M$335.68M
    Operating Expenses$273.20M$275.30M$282.30M$278.10M$268.20M$282.30M$283.58M$291.44M$253.62M$274.46M$268.11M$244.73M
    R&D$61.20M$62.90M$65.70M$71.30M$60.50M$73.50M$79.62M$91.00M$59.30M$63.98M$62.21M$43.53M
    SG&A$212.00M$212.40M$221.00M$206.80M$207.70M$208.80M$203.96M$200.44M$194.72M$214.88M$207.15M$201.20M
    Operating Income$72.60M$34.10M$61.90M$66.40M$77.10M$23.70M$58.33M$64.47M$101.50M$52.01M$97.79M$90.95M
    Interest Income$22.30M$21.00M$31.00M$13.70M$14.70M$36.20M$15.90M$15.50M$16.60M$34.00M$16.80M$17.30M
    Interest Expense$12.10M$12.30M$12.10M$12.30M$12.60M$12.00M$12.19M$12.17M$12.26M$12.28M$12.36M$12.40M
    Income Before Tax$542.10M$-689,800,000$929.20M$-431,100,000$414.00M$83.40M$-908,900,000$861.62M$-2,786,281,000$491.08M$428.39M$137.10M
    Income Tax Expense$170.70M$-162,700,000$209.20M$-89,200,000$96.20M$19.40M$-193,100,000$208.45M$-620,795,000$107.16M$78.68M$30.84M
    Net Income$371.40M$-527,100,000$720.00M$-341,900,000$317.80M$64.00M$-715,800,000$653.17M$-2,165,486,000$383.92M$349.71M$106.26M
    EBITDA$542.10M$-636,600,000$983.80M$-374,600,000$467.20M$133.50M$-847,400,000$912.69M$-2,737,617,000$540.46M$477.95M$186.80M
    EBIT$554.20M$-677,500,000$941.30M$-418,800,000$426.60M$95.40M$-896,700,000$873.79M$-2,774,017,000$503.36M$440.75M$149.50M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BIO-B

    News

    Bio-Rad Laboratories, Inc. Class A Revenue Breakdown – HAN:BUWA

    This article provides a financial breakdown of Bio-Rad Laboratories, Inc. Class A (BUWA) for the Hannover Stock Exchange. It highlights that the company generated 2.20 billion EUR last year...

    TradingView•9/29/26•Neutral

    Bio-Rad Laboratories, Inc. (BIO-B) Stock Price, News, Quote & History

    This Yahoo Finance page provides a comprehensive overview of Bio-Rad Laboratories, Inc. (BIO-B) stock, including its current price, historical data, key statistics...

    Yahoo! Finance Canada•9/24/26•Neutral

    Bio-Rad expands Foresight Pro prepacked chromatography columns with Nuvia ion exchange and mixed-mode resins

    Bio-Rad Laboratories has launched expanded Foresight Pro prepacked chromatography columns featuring Nuvia ion exchange and mixed-mode resins. This new range offers an effective solution for purifying biomolecules...

    Manufacturing Chemist•9/3/26•Neutral

    Bio Rad Laboratories (BIO) Stock Jumps As ddPCR Progress Meets Flat Demand

    Bio-Rad Laboratories' stock saw a 4.5% jump following its Q2 2026 earnings report, with revenue of US$651 million and non-GAAP EPS of US$2.62...

    Sahm•8/6/26•Neutral

    Bio-Rad Earnings: Modest Sequential Improvement, but Full-Year Guidance Ranges Remain Wide

    Bio-Rad reported a modest sequential improvement in its second-quarter earnings, with a 1.9% year-on-year revenue decline at constant currency and a non-GAAP operating margin of 12.5%. Despite this...

    Morningstar•8/5/26•Neutral

    BIO-B Valuation and Fair Value

    P/E
    44.1x
    Forward P/E
    39.8x
    EV/EBITDA
    20.3x
    P/FCF
    27.7x
    PEG
    1.2x
    P/B
    1.4x
    See GNG's fair value

    BIO-B Profitability: Margins, ROIC and FCF

    Gross margin
    51.9%
    Operating margin
    11.2%
    Net margin
    8.6%
    ROIC
    3.1%
    ROE
    3.1%
    FCF margin
    13.6%
    FCF yield
    3.6%

    BIO-B Competitors

    CompanyTicker
    Twist Bioscience CorpTWST
    Nuvalent IncNUVL
    The Ensign Group IncENSG
    Bio-Rad Laboratories IncBIO
    Apogee Therapeutics, Inc. Common StockAPGE
    Krystal Biotech IncKRYS
    Globus MedicalGMED
    Henry Schein IncHSIC

    Sector: Healthcare

    BIO-B Bull Case vs Bear Case

    Bear case

    • BIO-B trades at 44.1x trailing earnings.
    • BIO-B's quarterly revenue changed -0.1% year over year.

    BIO-B Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    114.5%

    Frequently Asked Questions About BIO-B

    Does BIO-B pay dividends?

    Bio-Rad Laboratories Inc (BIO-B) does not currently pay a regular dividend.

    What is BIO-B's P/E ratio?

    Bio-Rad Laboratories Inc has a price-to-earnings (P/E) ratio of 44.12.

    What is BIO-B's market cap?

    Bio-Rad Laboratories Inc (BIO-B) has a market capitalization of $9.76B with a current stock price of $364.15.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In